Latest Breaking News On - Immunovia dx laboratory in marlborough - Page 1 : comparemela.com

Following the telephone conference, a recording will be available on Immunovia s website (www.immunovia.com). For more information, please contact: Patrik Dahlen, CEO Immunovia Tel: +46 73 376 76 64 This is information that Immunovia is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 16.00 CET on April 28, 2021. About Immunovia Immunovia AB is a diagnostic company that is developing and commercializing highly accurate blood tests for the early detection of cancer and autoimmune diseases based on Immunovia s proprietary test platform called IMMray™. Tests are based on antibody biomarker microarray analysis using advanced machine-learning and bioinformatics to single-out a set of relevant biomarkers that indicate a certain disease. Thus, forming a unique disease biomarker signature .

United statesUnited kingdomPrnewswire immunoviaPatrik dahlenImmunovia dx laboratory in marlboroughDepartment of immuntechnology at lund universityHealth cancer centerLund universityCancer centerImmunovia dx laboratoryஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்பற்றிக் டஹ்லன்ஆரோக்கியம் புற்றுநோய் மையம்லண்ட் பல்கலைக்கழகம்புற்றுநோய் மையம்